Poly-Lactic Acid-Based Biopolymer Formulations Are Safe for Sustained Intratympanic Dexamethasone Delivery
Published inOtology & Neurotology, vol. 40, no. 7, p. e739-e746
Publication date2019
Abstract
Keywords
- Dexamethasone
- Drug delivery
- Hearing loss
- Inner ear
- Intratympanic therapy
- Menière's disease
- Otology
- Otoprotection
Funding
- Autre - Swiss Commission for Technology and Innovation (CTI Project 17673.2 PFLS-LS)
- Autre - Foundation AURIS, Geneva
Citation (ISO format)
ROUSSET, Francis et al. Poly-Lactic Acid-Based Biopolymer Formulations Are Safe for Sustained Intratympanic Dexamethasone Delivery. In: Otology & Neurotology, 2019, vol. 40, n° 7, p. e739–e746. doi: 10.1097/MAO.0000000000002305
Main files (1)
Article (Published version)
![accessLevelRestricted](assets/images/access-level-restricted.png)
Identifiers
- PID : unige:122173
- DOI : 10.1097/MAO.0000000000002305
- PMID : 31295207
ISSN of the journal1531-7129